Prognostic value of neutrophil gelatinase-associated lipocalin in patients with acute ST-segment elevation myocardial infarction: A meta-analysis

Abstract

Get full access to this article

View all access options for this article.

References

Piepoli

Corra

Dendale

et al.

Challenges in secondary prevention after acute myocardial infarction: A call for action. Eur J Prev Cardiol 2016; 23: 1994–2006.

Schiele

Ecarnot

Chopard

. Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention. Eur J Prev Cardiol 2017; 24: 88–100.

Wei

Mao

Liu

et al.

Serum biomarkers and the prognosis of AMI patients. Herz 2014; 39: 384–389.

Kaltsas

Chalikias

Tziakas

. The incidence and the prognostic impact of acute kidney injury in acute myocardial infarction patients: Current preventive strategies. Cardiovasc Drugs Ther 2018; 32: 81–98.

Martensson

Bellomo

. The rise and fall of NGAL in acute kidney injury. Blood Purif 2014; 37: 304–310.

Akcay

Ozlu

Sen

et al.

Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction. J Invest Med 2012; 60: 508–513.

Barbarash

Bykova

Kashtalap

et al.

Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction. BMC Cardiovasc Disord 2017; 17: 81–81.

Nymo

Hartford

Ueland

et al.

Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome. Int J Cardiol 2018; 262: 79–84.

Lindberg

Pedersen

Mogelvang

et al.

Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2012; 60: 339–345.

10.

Helanova

Littnerova

Kubena

et al.

Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: A prospective observational cohort study. BMJ Open 2015; 5: e006872–e006872.